AB Science : announces the filing of masitinib in the treatment of amyotrophic lateral sclerosis (ALS) to the European Medicines Agency

About Amyotrophic Lateral Sclerosis Amyotrophic lateral sclerosis is a rare degenerative ... About AB Science Founded in 2001, AB Science is a pharmaceutical company specializing in the research, development and commercialization of protein kinase ...
News Type: